Enterome - Articles and news items

Enterome starts Phase I Crohn’s disease trial

Industry news / 5 January 2017 / Niamh Marriott (Digital Editor)

Enterome has launched a Phase I clinical study with its lead drug candidate EB8018, a small molecule designed to block FimH, to treat Crohn’s disease…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+